These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 920249)

  • 1. Cerebrospinal fluid sorbitol and myoinositol in diabetic polyneuropathy.
    Servo C; Bergström L; Fogelholm R
    Acta Med Scand; 1977; 202(4):301-4. PubMed ID: 920249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.
    Servo C; Pitkänen E
    Diabetologia; 1975 Dec; 11(6):575-80. PubMed ID: 1205026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbitol and myoinositol levels in the cerebrospinal fluid of diabetic patients.
    Servo C
    Acta Endocrinol Suppl (Copenh); 1980; 238():133-7. PubMed ID: 6933810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.
    Greene DA; De Jesus PV; Winegrad AI
    J Clin Invest; 1975 Jun; 55(6):1326-36. PubMed ID: 124320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyols in the cerebrospinal fluid and plasma of neurological, diabetic and uraemic patients.
    Servo C; Palo J; Pitkänen E
    Acta Neurol Scand; 1977 Aug; 56(2):111-6. PubMed ID: 899715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic separation and mass spectrometric identification of polyols in human cerebrospinal fluid and plasma.
    Servo C; Palo J; Pitkänen E
    Acta Neurol Scand; 1977 Aug; 56(2):104-10. PubMed ID: 899714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of trapidil on neuropathy in diabetic mice].
    Inaba H; Kato K; Yano T
    Nihon Yakurigaku Zasshi; 1986 Aug; 88(2):95-9. PubMed ID: 3770591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats.
    Jefferys JG; Palmano KP; Sharma AK; Thomas PK
    J Neurol Neurosurg Psychiatry; 1978 Apr; 41(4):333-9. PubMed ID: 650240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway.
    Tigchelaar C; van Zuylen ML; Hulst AH; Preckel B; van Beek AP; Kema IP; Hermanides J; Absalom AR
    Diabetologia; 2022 Jul; 65(7):1098-1107. PubMed ID: 35380232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal myoinositol influx in human leucocytes in diabetes but not specifically in diabetic neuropathy.
    Simmons D; Ng LL; Bomford J
    Diabetes; 1992 Jun; 41(6):760-5. PubMed ID: 1587402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of myoinositol in plasma and red cells of diabetic patients.
    Servo C
    Acta Med Scand; 1977 Jan; 201(1-2):59-62. PubMed ID: 835372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose levels are markedly elevated in cerebrospinal fluid compared to plasma in pregnant women.
    Hwang JJ; Johnson A; Cline G; Belfort-DeAguiar R; Snegovskikh D; Khokhar B; Han CS; Sherwin RS
    PLoS One; 2015; 10(6):e0128582. PubMed ID: 26035307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of peripheral neuropathy in diabetes mellitus. Recent research findings and their therapeutic implications.
    Martin RA
    Postgrad Med; 1987 Sep; 82(3):183-7. PubMed ID: 3306636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of nerve sugar levels for the peripheral nerve impairment of spontaneously diabetic GK (Goto-Kakizaki) rats.
    Suzuki K; Yen-Chung H; Toyota T; Goto Y; Hirata Y; Okada K
    Diabetes Res; 1990 May; 14(1):21-5. PubMed ID: 2134662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders.
    Regenold WT; Kling MA; Hauser P
    Psychoneuroendocrinology; 2000 Aug; 25(6):593-606. PubMed ID: 10840171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
    Yasuda H; Sonobe M; Hatanaka I; Yamashita M; Miyamoto Y; Terada M; Amenomori M; Kikkawa R; Shigeta Y; Motoyama Y
    Biochem Biophys Res Commun; 1988 Jan; 150(1):225-30. PubMed ID: 3276309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis.
    Winegrad AI; Greene DA
    N Engl J Med; 1976 Dec; 295(25):1416-21. PubMed ID: 980097
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of erythrocyte sorbitol-blood glucose ratios in type II diabetes mellitus.
    Aida K; Tawata M; Shindo H; Onaya T
    Diabetes Care; 1990 May; 13(5):461-7. PubMed ID: 2351023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
    Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.